CYP2D6 inhibition increases levels of these drugs; QT prolongation risk
Avoid combination
Source: Kimi deep-research + Cla
Phenothiazine antipsychotic · Antipsychotic
Not yet extracted
CYP2D6 inhibition increases levels of these drugs; QT prolongation risk
Avoid combination
Source: Kimi deep-research + Cla
Increased risk of QTc prolongation, ventricular arrhythmias (e.g., Torsades de Pointes), and sudden cardiac death.
CONTRAINDICATED. Do not co-administer. A washout period of at least 5 weeks is required after discontinuing fluoxetine before starting thioridazine.
Source: DDInter
Significantly increased risk of severe QTc prolongation and potentially fatal arrhythmias (e.g., Torsades de Pointes). Both are potent QTc prolonging agents.
Concomitant use is contraindicated due to high risk of severe cardiac adverse events.
Increased risk of serious ventricular arrhythmias (e.g., Torsades de Pointes) and sudden death.
Concomitant use is contraindicated. A washout period is required when switching between these drugs.
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: metabolism
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy, metabolism
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team